abstract |
A method of treating bronchoalveolar carcinoma, carcinomatosis with lymphangitic spread or primary and metastatic lung cancers by administering one or more bioactive agents by inhalation of a lipid composition. The one or more bioactive agents preferably comprise cisplatin, carboplatin or a taxane. |